Securities Code: 300633 Securities Abbreviation: Keli Medical Announcement No.: 2026-030
Shenzhen Keli Medical Technology Co., Ltd. Announcement on the Completion of Share Repurchase and Changes in Share Capital
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Shenzhen Keli Medical Technology Co., Ltd. (hereinafter referred to as the "Company") held the Fourteenth Meeting of the Fourth Board of Directors on March 17, 2026, and the First Extraordinary Shareholders' Meeting of 2026 on April 3, 2026. The proposal on the repurchase of the Company's shares was deliberated and approved item by item. The Company agreed to use its own funds or raised funds (including funds from special stock repurchase loans, etc.) to repurchase shares through centralized bidding transactions, all of which will be cancelled to reduce registered capital. The total repurchase amount is not less than RMB 10,000,000 (inclusive) and not more than RMB 20,000,000 (inclusive). The specific total repurchase amount shall be based on the actual funds used upon the expiration of the repurchase period or the completion of the repurchase. The upper limit of the repurchase price is RMB 40.32 per share (inclusive). The implementation period for the repurchase of shares is within 12 months from the date the shareholders' meeting approved the current repurchase plan. For details, please refer to the "Announcement on the Company's Share Repurchase Plan" disclosed by the Company on the Juchao Information Network on March 18, 2026, and the "Repurchase Report" disclosed on April 3, 2026.
As of the date of this announcement, the repurchase of the Company's shares has been completed. In accordance with the "Regulations on Listed Company Share Repurchases," "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 9—Share Repurchases" (hereinafter referred to as "Supervisory Guidelines No. 9") and other relevant regulations, the results of the Company's share repurchase are hereby announced as follows:
I. Progress of the Company's Share Repurchase
- On April 9, 2026, the Company repurchased shares for the first time through a dedicated securities account for repurchases using centralized bidding transactions. For details, please refer to the "Announcement on the Company's First Share Repurchase" disclosed by the Company on the Juchao Information Network on April 10, 2026.
- On May 6, 2026, the Company disclosed the "Announcement on the Repurchase Proportion Reaching 1% of the Company's Total Share Capital and the Progress of the Repurchase" on the Juchao Information Network.
- As of May 14, 2026, the Company had cumulatively repurchased 7,874,900 shares of the Company through a dedicated securities account for repurchases using centralized bidding transactions, accounting for 1.82% of the Company's current total share capital. The highest transaction price was RMB 28.15 per share, and the lowest transaction price was RMB 23.28 per share. The transaction amount was RMB 199,935,791.16 (excluding transaction fees). This repurchase complies with relevant laws, regulations, normative documents, and the Company's share repurchase plan.
II. Explanation of No Discrepancy Between Repurchase Implementation and Repurchase Plan
The total amount of funds actually used by the Company for this repurchase has reached the upper limit of the repurchase fund specified in the repurchase plan, and the share repurchase plan has been implemented. There are no discrepancies between the actual number of shares repurchased, the amount of funds used, the repurchase time, and the price range, and the share repurchase plan deliberated and approved by the Board of Directors.
III. Impact of This Repurchase on the Company
This repurchase will not have a significant impact on the Company's operations, financial status, research and development, debt-paying ability, and future development. It will not lead to a change in the Company's control, nor will it affect the Company's listing status. The Company's shareholding structure still meets the listing conditions. This share repurchase reflects the management's affirmation of the Company's intrinsic value and confidence in its future sustainable development, which is conducive to protecting the interests of all shareholders.